A mély agyi stimuláció szerepe az epilepszia kezelésében

Translated title of the contribution: Role of deep brain stimulation in epilepsy

J. Janszky, István Balás, N. Kovács

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The deep brain stimulation (DBS) is an emerging treatment option in brain disorders in which randomized multicenter trials proved its efficacy leading to licensing different DBS methods in various brain diseases. More recently more and more brain structures have become candidates for being "target" in a possible DBS treatment of epilepsy. At present, only the DBS of the anterior nucleus of the thalamus (ANT) can be considered as a proved method for epilepsy treatment. Other potential targets for DBS treatment in epilepsy are the subthalamic nuclei, and the amygdala-hippocampus complex. There are some ongoing randomized studies to investigating their therapeutical role. The therapeutical outcome of ANT-DBS treatment in drug-resistant epilepsy seems to be better than the new antiepileptic drugs, but much worse than the results of a potential epilepsy surgery. At about 10% of patients may become seizure-free and 50% of patients may have a significant improvement. Nowadays ANT-DBS should be considered as an "ultima ratio" in those adult drug-resistant epilepsy patients with normal intelligence in which neither new antiepileptic drugs nor resective epilepsy surgery are a reasonable therapeutical options.

Original languageHungarian
Pages (from-to)317-320
Number of pages4
JournalIdeggyógyászati szemle
Volume64
Issue number9-10
Publication statusPublished - Sep 30 2011

Fingerprint

Deep Brain Stimulation
Epilepsy
Anterior Thalamic Nuclei
Brain Diseases
Anticonvulsants
Therapeutics
Subthalamic Nucleus
Licensure
Amygdala
Intelligence
Multicenter Studies
Hippocampus
Seizures
Brain

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

A mély agyi stimuláció szerepe az epilepszia kezelésében. / Janszky, J.; Balás, István; Kovács, N.

In: Ideggyógyászati szemle, Vol. 64, No. 9-10, 30.09.2011, p. 317-320.

Research output: Contribution to journalArticle

@article{401ebc8e78c34b6e89fd35698d1c3726,
title = "A m{\'e}ly agyi stimul{\'a}ci{\'o} szerepe az epilepszia kezel{\'e}s{\'e}ben",
abstract = "The deep brain stimulation (DBS) is an emerging treatment option in brain disorders in which randomized multicenter trials proved its efficacy leading to licensing different DBS methods in various brain diseases. More recently more and more brain structures have become candidates for being {"}target{"} in a possible DBS treatment of epilepsy. At present, only the DBS of the anterior nucleus of the thalamus (ANT) can be considered as a proved method for epilepsy treatment. Other potential targets for DBS treatment in epilepsy are the subthalamic nuclei, and the amygdala-hippocampus complex. There are some ongoing randomized studies to investigating their therapeutical role. The therapeutical outcome of ANT-DBS treatment in drug-resistant epilepsy seems to be better than the new antiepileptic drugs, but much worse than the results of a potential epilepsy surgery. At about 10{\%} of patients may become seizure-free and 50{\%} of patients may have a significant improvement. Nowadays ANT-DBS should be considered as an {"}ultima ratio{"} in those adult drug-resistant epilepsy patients with normal intelligence in which neither new antiepileptic drugs nor resective epilepsy surgery are a reasonable therapeutical options.",
keywords = "Deep brain stimulation, Epilepsy, Epilepsy surgery, Thalamus, Therapy resistance",
author = "J. Janszky and Istv{\'a}n Bal{\'a}s and N. Kov{\'a}cs",
year = "2011",
month = "9",
day = "30",
language = "Hungarian",
volume = "64",
pages = "317--320",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "9-10",

}

TY - JOUR

T1 - A mély agyi stimuláció szerepe az epilepszia kezelésében

AU - Janszky, J.

AU - Balás, István

AU - Kovács, N.

PY - 2011/9/30

Y1 - 2011/9/30

N2 - The deep brain stimulation (DBS) is an emerging treatment option in brain disorders in which randomized multicenter trials proved its efficacy leading to licensing different DBS methods in various brain diseases. More recently more and more brain structures have become candidates for being "target" in a possible DBS treatment of epilepsy. At present, only the DBS of the anterior nucleus of the thalamus (ANT) can be considered as a proved method for epilepsy treatment. Other potential targets for DBS treatment in epilepsy are the subthalamic nuclei, and the amygdala-hippocampus complex. There are some ongoing randomized studies to investigating their therapeutical role. The therapeutical outcome of ANT-DBS treatment in drug-resistant epilepsy seems to be better than the new antiepileptic drugs, but much worse than the results of a potential epilepsy surgery. At about 10% of patients may become seizure-free and 50% of patients may have a significant improvement. Nowadays ANT-DBS should be considered as an "ultima ratio" in those adult drug-resistant epilepsy patients with normal intelligence in which neither new antiepileptic drugs nor resective epilepsy surgery are a reasonable therapeutical options.

AB - The deep brain stimulation (DBS) is an emerging treatment option in brain disorders in which randomized multicenter trials proved its efficacy leading to licensing different DBS methods in various brain diseases. More recently more and more brain structures have become candidates for being "target" in a possible DBS treatment of epilepsy. At present, only the DBS of the anterior nucleus of the thalamus (ANT) can be considered as a proved method for epilepsy treatment. Other potential targets for DBS treatment in epilepsy are the subthalamic nuclei, and the amygdala-hippocampus complex. There are some ongoing randomized studies to investigating their therapeutical role. The therapeutical outcome of ANT-DBS treatment in drug-resistant epilepsy seems to be better than the new antiepileptic drugs, but much worse than the results of a potential epilepsy surgery. At about 10% of patients may become seizure-free and 50% of patients may have a significant improvement. Nowadays ANT-DBS should be considered as an "ultima ratio" in those adult drug-resistant epilepsy patients with normal intelligence in which neither new antiepileptic drugs nor resective epilepsy surgery are a reasonable therapeutical options.

KW - Deep brain stimulation

KW - Epilepsy

KW - Epilepsy surgery

KW - Thalamus

KW - Therapy resistance

UR - http://www.scopus.com/inward/record.url?scp=80054772250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054772250&partnerID=8YFLogxK

M3 - Article

C2 - 22059367

AN - SCOPUS:80054772250

VL - 64

SP - 317

EP - 320

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 9-10

ER -